These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3876624)

  • 21. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane.
    Cohen PL; Eisenberg RA
    Immunol Today; 1992 Nov; 13(11):427-8. PubMed ID: 1282318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavior and immune status of MRL mice in the postweaning period.
    Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
    Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
    J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.
    Mixter PF; Russell JQ; Durie FH; Budd RC
    J Immunol; 1995 Mar; 154(5):2063-74. PubMed ID: 7868883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of c-myb transcription in autoimmune disease by cyclophosphamide.
    Mountz JD; Mushinski JF; Smith HR; Klinman DM; Steinberg AD
    J Immunol; 1985 Oct; 135(4):2417-22. PubMed ID: 4031495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial expression of the lpr locus in the heterozygous state: presence of autoantibodies.
    Jachez B; Montecino-Rodriguez E; Fonteneau P; Loor F
    Immunology; 1988 May; 64(1):31-6. PubMed ID: 3260217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
    Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I.
    Zhou T; Edwards CK; Yang P; Wang Z; Bluethmann H; Mountz JD
    J Immunol; 1996 Apr; 156(8):2661-5. PubMed ID: 8609380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
    J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the lpr environment on the lymph node cell phenotypes in C57BL/6 nubg and nulpr chimeras.
    Tiberghien F; Ceredig R; Loor F
    Immunology; 1994 Dec; 83(4):552-61. PubMed ID: 7875735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic norepinephrine is decreased in MRL-lpr/lpr mice.
    Breneman SM; Moynihan JA; Grota LJ; Felten DL; Felten SY
    Brain Behav Immun; 1993 Jun; 7(2):135-43. PubMed ID: 8347895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
    Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
    J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
    Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.